Resources from the same session
Anti–PD-(L)1s plus chemotherapies continue to evolve: Updates from 2023 congresses
Presenter: Ilaria Colombo
Session: GSK - The breakthrough era in endometrial cancer treatment
Resources:
Webcast
Synergy: Is it more than a buzzword for IO plus PARPi or TKI?
Presenter: Kathleen Moore
Session: GSK - The breakthrough era in endometrial cancer treatment
Resources:
Webcast
Surge in molecular-based targets brings new hope for EC treatment
Presenter: All Speakers
Session: GSK - The breakthrough era in endometrial cancer treatment
Resources:
Webcast
Full discussion/Q&A
Presenter: All Speakers
Session: GSK - The breakthrough era in endometrial cancer treatment
Resources:
Webcast